PRPO.NASDAQPrecipio, INC

Form 4: Precipio CFO Matthew Gage Reports Option Repricing

Sentiment:

SEC Form 4


Matthew Gage, CFO of Precipio, Inc., reports adjustments to stock options, including repricing to $6.56, effective August 31, 2024.

Summary

  • Matthew Gage, the Chief Financial Officer of Precipio, Inc., filed a Form 4 on September 6, 2024, reporting changes in his beneficial ownership due to an option repricing.
  • The repricing, approved by the Board of Directors on August 30, 2024, became effective on August 31, 2024.
  • Gage's stock options were repriced to $6.56 per share, reflecting the fair market value of Precipio's common stock on the effective date.
  • The repriced options will revert to their original exercise price if Gage's service is terminated with cause or by Gage himself, or if the option is exercised before the first anniversary of the effective date.
  • The filing details the acquisition and disposal of various stock options with different original exercise prices and expiration dates, all adjusted as part of the repricing.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily describes an administrative action (option repricing) with standard terms. It's neither overwhelmingly positive nor negative from an investment perspective.

Positives

  • The option repricing could incentivize the CFO by aligning his interests with the company's current stock value.
  • The repricing is intended to retain key personnel by making stock options more attractive.

Risks

  • The repriced options reverting to their original price if the CFO's service is terminated with cause or by the CFO himself before the first anniversary of the effective date could be a risk.
  • The repricing may dilute existing shareholders' equity if the options are exercised in the future.

Future Outlook

The document does not contain specific forward-looking statements beyond the terms of the option repricing.

Management Comments

  • The Issuer's Board of Directors approved an option repricing (the 'Repricing'), effective as of August 31, 2024 (the 'Effective Date').
  • All of the other terms of the options remain unchanged.

Industry Context

Option repricing is a common practice to incentivize employees, especially when a company's stock price has declined. This move aims to retain and motivate key executives by making their stock options more valuable.

Comparison to Industry Standards

  • Option repricing is a fairly common practice, especially in smaller companies or those experiencing stock price volatility.
  • Companies like Novavax and Cassava Sciences have also used option repricing to retain key employees during challenging times.
  • The specific terms, such as the reversion clause if employment is terminated, are fairly standard in executive compensation packages.

Stakeholder Impact

  • Shareholders may experience dilution if the options are exercised.
  • Employees with options will see a change in the exercise price, potentially increasing the value of their options.
  • The repricing aims to retain key personnel, which could benefit the company's long-term performance.

Key Dates

DateDescription
08/30/2024Issuer's Board of Directors approved an option repricing.
08/31/2024Effective date of the option repricing.
09/06/2024Date of Form 4 filing.
02/16/2028Expiration date of some stock options.
03/18/2029Expiration date of some stock options.
01/16/2030Expiration date of some stock options.
10/20/2030Expiration date of some stock options.
01/04/2031Expiration date of some stock options.
08/07/2031Expiration date of some stock options.
01/11/2032Expiration date of some stock options.

Keywords

stock options, Precipio, Gage, repricing, CFO, Form 4, beneficial ownership, securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.